FSTL3-Driven Cuproptosis Resistance and EPCs Promote OSCC Metastasis
Researchers identified FSTL3 as a key driver of oral cancer spread to lymph nodes through two mechanisms: helping cancer cells resist a form of cell death and suppressing immune responses by recruiting immunosuppressive cells. Blocking FSTL3 combined with immunotherapy showed promise in preventing metastasis.
A plain-English summary of the study's own findings — we don't add our own claims or interpretation. Read the full paper for the complete methods and results, and apply your own clinical judgement.
Read the full study at the sourceThe Recall — the month's most significant new dental research, summarised. Free.
Browse The Recall